Skip to main content
Top

Journal of Radiation Oncology

Issue 4/2017

Content (11 Articles)

Open Access Review

Intratumoral treatment with radioactive beta-emitting microparticles: a systematic review

Robbert C. Bakker, Marnix G.E.H. Lam, Sebastiaan A. van Nimwegen, Antoine J.W.P. Rosenberg, Robert J.J. van Es, J. Frank W. Nijsen

Original Research

Fractionation trends in breast cancer and implications in partial breast irradiation

Daniel M. Trifiletti, Timothy N. Showalter, Kara D. Romano, Einsley Janowski, Shayna L. Showalter, Surbhi Grover

Original Research

Analysis of treatment effectiveness and complications associated with MammoSite™ breast brachytherapy in patients treated at a single institution

Daniel H. Miller, Nicholas Pflederer, Timothy Malouff, Don R. Nguyen, Elizabeth Edney, Edibaldo Silva-Lopez, William Hunter, Cam Nguyen

Original Research

Active monitoring in non-invasive breast cancer: insight gained from a large national database

Daniel M. Trifiletti, Surbhi Grover, Bertram W. Maidment III, Timothy N. Showalter, Shayna L. Showalter

Original Research

Hemostatic radiotherapy in advanced bladder cancer: a single-institution experience

Saif Aljabab, Peter Cheung, Kristopher Dennis, Scott C. Morgan

Original Research

Maximizing survival in patients with muscle-invasive bladder cancer undergoing curative bladder-preserving radiotherapy: the impact of radiotherapy dose escalation

Mark Korpics, Alec M. Block, Basel Altoos, Brendan Martin, Kyle Carey, James Welsh, Matthew M. Harkenrider, Abhishek A. Solanki

Original Research

Stereotactic ablative radiotherapy with targeted MRI-defined gross tumor dose escalation for prostate cancer: dosimetric feasibility and interfraction robustness

Ali Hosni, Vickie Kong, Tara Rosewall, Andrew Bayley, Cynthia Ménard, Peter Chung, Alejandro Berlin

Original Research

Defining an “ideal” continuous dose-volume constraint curve using literature recommended individual dose-volume thresholds for reducing rectal toxicity from external beam prostate radiation therapy

Ravindra Yaparpalvi, Madhur K. Garg, Nitin Ohri, William R. Bodner, Wolfgang A. Tomé, Chandan Guha, Shalom Kalnicki

Open Access Original Research

Influence of radiation treatment technique on outcome and toxicity in anal cancer

Elisha T. Fredman, May Abdel-Wahab, Aryavarta M.S. Kumar

Original Research

The effect of resveratrol administration in irradiated mice on the induction of micronuclei in bone marrow

Farideh Koohian, Ahmad Shanei, Daryoush Shahbazi-Gahrouei, Seyed Hossein Hejazi, Amirhossein Ahmadi, Mohammadreza Sharifi

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine